• About
  • Subscribe
  • Advertise
  • Contact
Saturday, June 14, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Allergan and Valeant agree on meeting date truce for moment

by Staff Writer
October 11, 2019
in News
Reading Time: 3 mins read
A A
Share on FacebookShare on Twitter

On 15 Septber, Allergan announced that it had agreed to hold the special meeting on its originally scheduled date of 18 Decber. In return, its hostile suitors have dropped their pending lawsuit, which was meant to speed up the meeting and thwart any defensive M&A attpts by the Botox and ophthalmic-products manufacturer and distributor.
At the meeting, Pershing Square chief Mr Bill Ackman hopes to overturn Allergan’s board and replace the majority of its directors with a new, deal-friendlier slate.
Squabbling over the meeting date spurred lawsuits on both sides. Allergan, which has repeatedly termed Valeant’s bid “grossly inadequate”, has until recently done what it could to block the meeting. In August, it sued the Valeant-Ackman team, accusing the duo of insider trading; while Allergan will continue to pursue that litigation, it will stop trying to delay or cancel the meeting.
Now, with the date of the meeting finally set, both sides will gear up for the shareholder vote that could seal their fates. Valeant chief executive officer Mr Michael Pearson, for one, says he’s confident his company will prevail, noting in June that “both sides know how this will come out”.
But according to analysts, Allergan still has time to use some M&A of its own to keep shareholders loyal. Completing a deal -especially one of the tax-inversion variety – could make Allergan too big for Valeant to swallow and potentially negate the low tax rate Valeant has put forth for a combined company.
It’s been five months since activist investor Mr Ackman and Valeant teamed up to make their first play for Allergan. After nearly half a year of lawsuits, trading barbs and vying for investor favor, Mr Ackman now says it’s time for the Allergan’s board to “wake up”.
In a letter of 10 Septber, Mr Ackman urged Allergan’s directors to listen to what Valeant is putting on the table and assured th that they could still “rescue” their reputations by taking over leadership from chief executive officer Mr David Pyott.
“Your actions have wasted corporate resources, delayed enormous potential value creation for shareholders, and are professionally and personally barrassing for you,” Mr Ackman said in his letter, calling Allergan’s battle for independence “the most shareholder-unfriendly, hostile defence process perhaps in the history of corporate America”.
The directors’ jobs could go the way of their reputations, in Mr Ackman’s eyes.
As part of the duo’s hostile takeover attpt, Mr Ackman drafted a slate of deal-friendly directors back in July that he hopes to have installed at a special shareholder meeting in Decber.
Some analysts say he has a decent chance as Valeant and Ackman have a 50-60 per cent chance of winning enough support to replace the majority of the board despite the fact that only 33.8% of shareholders voted to call the special meeting itself.

Related Posts

Advanced practice orthoptists Kylie Robinson (left) and Debra Gleeson have enjoyed the extra training and responsibility in the Eye and Ear pilot: Image: Eye and Ear.

Eye and Ear pilot gives orthoptists greater scope of practice

by Staff Writer
June 13, 2025

A new pilot program in the Royal Victorian Eye and Ear Hospital’s Acute Ophthalmology Services is boosting the clinic’s efficiency...

Victorian Virtual Specialist Consults

Optometrists can now access ophthalmology advice via Victorian Virtual Specialist Consults service

by Staff Writer
June 13, 2025

Optometrists can now access the Victorian Virtual Specialist Consults (VVSC) service for online access to an ophthalmologist for advice on...

The Dry Eye Society is holding training for its members in Brisbane in July.  Image: Pormezz/stock.adobe.com

Dry Eye Society announces wet lab training event

by Staff Writer
June 13, 2025

The Dry Eye Society has announced a members-only wet lab event, which will  deliver advanced, hands-on clinical training in dry eye management....

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited